Characteristics of 46 patients | Results |
---|---|
Age [years], mean, standard deviation | 71, 6.9 |
PSA value [ng/ml], median, range | 3.76, 0.32–113.7 |
Disease duration [months], median, range | 41, 0–192 |
Days between [68Ga]-Ga-PSMA-11 and [18F]-F-PSMA-1007, mean, standard deviation, median | 12, 8.0, 13 |
Indication [n; %] | |
Primary staging | 10; 21.7% |
Biochemical recurrence | 30; 65.2% |
After RPx | 26 (86.7%) |
After RTx/Brachytherapy | 4 (13.3%) |
Follow-up/PRLT-evaluation | 6; 13.0% |
Gleason score (GSC) | n |
---|---|
6 | 2 (4.3%) |
7 | 20 (43.5%) |
8 | 6 (13.0%) |
9 | 18 (39.1%) |
10 | 0 |